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Abstract 
Increased activity of the alpha adrenergic nervous system 
may be a significant factor promoting tissue ischemia in 
endotoxic shock. The suggestion that increased sympathetic 
acti vi ty affects prostaglandin synthesis prompted investigation 
of the potential interaction between the adrenergic nervous 
system' and arachidonic acid metabolites during endotoxemia and 
septicemia. In addition, the possibility that the underlying 
patterns of arachidonic acid metabolites seen in two different 
shock models may provide a rationale for therapeutic intervention 
designed to block either or both the synthesis of arachidonic 
acid metabolites or the activity of the adrenergic nervous system 
was examined. Studies were undertaken to determine the effects 
of the alpha receptor antagonist, phenoxybenzamine (POB), and the 
cyclooxygenase inhibitor, indomethacin (INDO), on plasma 
thromboxane (TxA2) and prostacyclin (PGI2) in endotoxin-induced 
shock. Rats were pretreated with POB (1 mg/kg i.v.) and/or INDO 
( 10m g /k g i. v.) 30m in ute s p rio r to i. v. ad rn i n is t rat ion 0 f 8 
mg/kg s. enteritidis endotoxin (LDao). Animals were bled at 30 
minutes and 4 hours post-endotoxin for determination of blood 
glucose, plasma beta-glucuronidase (BG), aspartate amino 
transferase (AST), and hematocrit as indicators of shock 
severity. Plasma was also taken at these intervals for 
radioimmunoassay of the stable immunoreactive metabolites of TxA2 
and PGI2, iTxB2 and i6-keto-PGFla' respectively. Pretreatment 
with INDO alone reduced endotoxin-induced hypoglycemia (P<O.05). 
POB pretreatment reduced hypoglycemia, hemoconcentration and beta 
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glucuronidase (P<O.05). The combination of POB and INDO resulted 
in the improvement of all these indices of shock severity 
(P<O.05). Rats pretreated with POB and INDO alone or conjointly 
also exhibited significantly (P<O.05) enhanced survival compared 
to shocked control rats. Elevations in arachidonic acid 
metabolites were attenuated by POB pretreatment. In endotoxin-
treated rats (15 mg/kg i.v.), the mean plasma iTxB 2 value at 30 
mins post-endotoxin was 1532 + 319 pg/ml (N=1 0). POB 
pretreatment decreased iTxB2 to 719 + 114 pg/ml (N=10) (P<.05). 
Plasma i6-keto-PGF1a was increased at 4 hrs after endotoxin to 
4161 + 885 pg/ml (N=5) in shocked controls. POB attenuated this 
increase to 1184 + 363 pg/ml (N=4) (P<O.05). The da ta 
demonstrate that the alpha receptor antagonist POB inhibits the 
increased synthesis of arachidonic acid metabolites seen in 
endotoxemia. The reduction in more indices of shock severity in 
rats receiving combined POB and INDO pretreatment suggest that 
nonsteroidal anti-inflammatory agents may be an effective adjunct 
to alpha adrenergic blocking agents in endotoxin shock. 
Other experiments were undertaken to: 1) determine the 
effects of POB and INDO, individually, on mean arterial pressure 
(MAP), heart rate (HR), and MAP respons;~ to injected 
no repinephr ine (NE) in control rats and endotoxin shocked rats, 
2) assess the effect of POB on iTxB2 and i6-keto-PGF1a 
synthesis, and 3) determine the effects of POB and INDO, 
independently and conjointly, on survival from shock induced by 
intraperitoneal injection of feces. The data demonstrate that 
POB (1 mg/kg) leads to a reduction in MAP in unshocked rats, but 
does not significantly exacerbate endotoxin-induced hypotension. 
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POB administration also effected a 60% - 90% reduction in the MAP 
response to injection of NE in shocked and unshocked rats. No 
consistent effect on heart rate in shocked and unshocked animals 
was observed with POB. Pretreatment with INDO (10 mg/kg) did not 
significantly alter MAP, HR, or the MAP response to exogenous NE 
in normal rats and rats challenged with endotoxin. 
In the intraabdominal sepsis model (LD 100 within 48 hrs), 
pretreatment with POB did not increase survival time while INDO, 
independently or conjointly with POB, prolonged survival time 
compared to controls and animals treated only with POB (P<0.05). 
Treatments did not alter mortality (100% within 48 hrs). The 
effect of the combination of INDO + POB on survival time was not· 
significantly different from that of INDO alone (P)O.OS). 
Preliminary results suggest that POB pretreatment may suppress 
the elevations of iTxB2 and i6-keto-PGF1a in this shock model. 
The results are consistent with the hypothesis that the 
prevailing plasma levels of iTxB2 and i6-keto-PGF1a' which have 
different patterns in the two shock models studied, may playa 
role in determining the therapeutic efficacy of POB. 
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BACKGROUND AND SPECIFIC AIMS 
__ ~NIFICANCE AND BACKGROUND 
Septic and endotoxin shock are characterized by a series of 
biological events including increased activity of the sympathetic 
nervous system with catecholamine release, renin-angiotensin 
system activation, disseminated intravascular coagulation (Ole), 
lysosomal enzyme release, altered liver metabolism, hypoglycemia, 
and production and release of prostaglandins (Wardle, 1979). The 
marked increase in activity of the sympathoadrenal system 
immediately following the endotoxin insult is, in part, a 
protective response of the cardiovascular system to maintain 
cardiac output and blood pressure. However, intense 
vasoconstriction, while ma1ntaining blood flow to vital organs 
such as the brain and heart, impairs perfusion of other vascular 
beds such as the kidney and splanchnic viscera. With progressive 
ischemia of these tissues, and accumulation of metabolic products 
in the later phases of shock, there is a reduction of myocardial 
contracti li ty, depressed vascu lar reacti vi ty to ci rculating 
catecholamines, and increased likelihood of intravascular 
clotting. All of these contribute to terminal hypotension and 
death (Sproul and Mullaney, 1974). 
Sympathetic Involvement 
Hyperactivation of the sympathoadrenal system 1S generally 
considered to be a major sequela of endotoxin shock, as suggested 
by elevated plasma levels and tissue depletion of catecholamines 
found in a variety of endotoxic models (Pardini et al., 1982). 
Additional supporting evidence includes experiments involving 
suppression of sympathetic activity and the use of adrenergic 
1 
receptor blockers (Lillehei et al., 1972; Filkins, 1979). 
Investigations in which pressor drugs were used during 
endotoxic shock appear to implicate sympathoadrenal hyperactivity 
in subsequent pathophysiology. Lillehei et al. (1964), in 
experiments with metarminol, demonstrated that additional 
vasoconstriction in shock usually accelerates the onset of death. 
Phenoxybenzarnine (POB) selectively binds to alpha adrenergic 
receptors, increasing vessel diameter by reducing sympathetic 
vasoconstriction. Other vasodilator drugs, for the most part, 
appear to be less effective in endotoxin shock because they 
either have only temporary action or exert a negative 
chronotropic effect (Hardaway, 1980). A number of studies have 
investigated the use of blocking agents such as POB to 1mprove 
survival in endotoxin shock. In early shock when there is 
intensive vasoconstriction in organs excluding the heart and 
brain, POB has been shown (Hardaway, 1980) to decrease pulmonary 
hypertension, peripheral resistance, and central venous pressure 
while increasing cardiac index. Other effects of POB include the 
follow ing: increasing renal plasma flow, glomerular filtration, 
and urine output (Vick, 1964); and improved GOT, and plasma K+ 
(Dadkar et al., 1972). 8ruza's (1975) experiment~ using POB have 
likewise suggested that alpha blockade in endotoxin shock leads 
to a reduction of splanchnic ischemia. Filkins (1979), in 
comparing alpha and beta receptor blockade in endotoxin shock, 
~eported that alpha blockade resulted in a marked decrease in 
thality while beta blockade sensitized the rats to endotoxin. 
:his study emphasized the metabolic effects of alpha receptor 
blockade, resulting in enhanced gluconeogenesis. Beta blockade, 
2 
in contrast, was associated with depressed gluconeogenesis and 
hypoglycemia. 
Although the preceeding suggest alpha receptor blockade 
improves an organism's defense against endotoxin, not all 
investigators are in agreement. Abrams et al., (1969) concluded 
that low doses of POB given before and after endotoxin 
administration neither prevented death nor prolonged survival. 
However, Brake et aI, (1964) suggest that POB, although not 
beneficial by itself, may ameliorate the pathophysiologic changes 
in shock if given conjointly with additional treatment such as 
plasma volume expanders. 
The lack of agreement concerning the efficacy of POB in 
shock therapy suggested by Brake et al., (1964) may be a 
consequence of a number of variables including differences in 
type of shock and shock severity, different experimental animals, 
different dosages of the drug, and different times of drug 
administration (Skjoldburg, 1968). 
Prostaglandin Involvement 
In addi tion to sympathoadrenal system acti vation and 
increased catecholamine release, p~asma levels ot prostaglandins 
have been shown to be elevated during endotoxin shock (Isakson et 
al., 1977; Jakschik et al., 1974), and there is considerable data 
suggesting their involvement in both endotoxin and septic shock 
(Fletcher and Rarnwell, 1980ai Bult and Herman, 1982). These 
studies have directed attention to the importance of two 
metabo Ii te s of a rachidoni c ac i di thromboxane A2 (TxA2) and 
prostacyclin (PGI 2). These are potent vasoactive compounds and 
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mediators of platelet aggregation whose opposing effects 
suggested a potential role in the cardiovascular sequelae of 
shock. Harris et al., (1980) have shown that increased levels of 
PGI2 parallel the systemic hypotension in late shock, and that 
the early plasma thromboxane concentration increase correlates 
temporally with pulmonary hypertension. Further evidence for the 
involvement of these metabolites has been provided by the 
laboratories of Cook, Wise, and Halushka (see review, 1984). 
These investigators have used two shock models to examine 
alterations in the TxA2/PGI2 ratio and the contribution of these 
changes to the cardiovascular sequelae of shock. 
In the rat bolus endotoxin model, plasma thromboxane 
increases markedly in the early phases, i.e., within 30 minutes, 
and then decreases by 4 hrs to control values while prostacyclin 
levels, initially low, show a gradual increase to high levels in 
late shock (Fig. 1 ; Cook et al., 1984). A similar time course 
of alterations in the ratio of thromboxane and prostacyclin has 
a+so been reported for other species ranging from the baboon 
(Harris et al., 1980) to the cat (Coker et al., 1981). Selective 
inhibition by several different chemical classes of thromboxane 
synthetase inhibitors has shown improved cardiovascular 
performance as well as improved survival (Tempel et al., 1982; 
Cook et al., 1984). These results suggest that the vasopressor 
and/or platelet aggregatory actions of thromboxane are 
deleterious in endotoxin shock. 
Fig 1: Changes in plasma levels of iTxB2 and i6-keto-PGF1a 
over the course of bolus endotoxin shock (reprinted with 
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In contrast to the endotoxin model, shock induced by acute 
abdominal sepsis in the rat is characterized by lower thromboxane 
levels which are relatively unchanged throughout the course of 
shock. Prostacyclin increases early in shock to levels six to 
eight times greater than that of thromboxane at most intervals 
studied (Fig. 2; Cook et al., 1984). The pattern of release of 
arachidonic acid metaboli tes clearly differs in the two models. 
Additionally, pretreatment with thromboxane synthetase inhibitors 
is not protective in this septic model as it is in the endotoxin 
model. Thus, Tx synthetase inhibitors may be of no benefit in 
shock states characterized by high PGI2/TxA2 ratios. I·t is 
noteworthy, however, that treatment with fatty acid 
cyclooxygenase inhibitors, essential fatty acid deficiency, and 
antibiotic treatment do prolong survival (review by Cook et al., 
1984). It has also been reported that conjoint treatment, 
gentamicin with either cyclooxygenase inhibitors or essential 
fatty acid deficiency synergistically enhanced survival (Cook et 
al., 1984). Thus it appears that the pattern of release of 
arachidonic acid metabolites may dictate which and when 
therapeutic interventions are most effective. 
Interaction of Arachidonic Acid Metabolites and the Sympathetic 
Nervous System 
The preceeding has documented both increased adrenergic 
acti vi ty and arachidonic acid metabolism in shock and has 
suggested a major role of these vasoactive substances in 
modulating vascular tone and hence, organ blood flow. It is now 
apparent that there is a complex interaction between various 
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Fig 2: Changes in plasma levels of TxB2 (hollow circles) and 6-
keto-PGF1a (solid circles) during fecal peritonitis 


























(7 - 9 hrs terminal) 
(7 - 9 hrs terminal) 




vasoacti ve compounds such as catecholamines and prostaglandins. 
Norepinephrine has been shown to stimulate release of 
prostaglandins from organs such as the kidney (Needleman et al., 
1974; Dunn et al., 1978), the heart (Needleman, 1974), and blood 
vessels (Grodzinska and Gryglewski, 1980). Neri Serneri et ale --
(1981) noted that in many instances involving adrenergic 
stimulation, the ratio of TXA2/PGI2 was 1/35. The increased 
concentration of PGI2 compared to TxA2 was suggested to be 
necessary to moderate the vasoconstriction response to adrenergic 
stimulation. As noted previously, PGI2 is a potent vasodilator 
with actions that oppose those of vasoconstrictor hormones. 
Stimulation of arachidonic acid metabolism by vaso-
constrictor hormones such as norepinephrine (NE) may be a feature 
of processes mode rating thei r re lease or vascula r effects. 
Prostaglandins may playa role in regulating vascular tone by 
acting directly on the vascular smooth muscle, modulating 
sympathetic neurotransmission, or influencing the activity of 
vasoactive compounds (Malik, 1978). Evidence that endogenous 
prostaglandins affect vascular responsiveness to adrenergic 
stimulation derives largely from experiments in which 
sympathetically induced vasoconstriction is modified by 
increasing or decreasi~g arachidonic acid metabolism. Inhibition 
of cyclooxygenase with indomethacin and similar compounds has 
increased the vasoconstriction effected by sympathetic 
stimulation or NE infusion in vascular beds ranging from the 
spleen (Moncada and Vane, 1979) to the mesenteries (Malik et al., 
1976 ). Goto et ale (1 980) suggested that indomethacin, by 
inhibiting prostaglandin synthesis, potentiated responses to 
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elevated catecholamines induced by endotoxin shock, thus 
increasing vascular resistance and accelerating cell damage. By 
contrast, increased prostaglandin synthesis by arachidonic acid 
infusion has been demonstrated to reduce sympathetic 
vasoconstriction response in these same beds (Moncada and Vane, 
1979; Malik et al., 1976). PGE1 and PGE2 have been shown to 
interfere with sympathetic neuroeffector function by acting both 
pre and post junctionallYi this direct effect on sympathetic 
nerve stimulation was separated from any vascular effects that 
these prostaglandins might have (Hedqvist, 1971). PGE thus 
appears to act as a physiological brake mechanism for release of 
catecholamines (Malik, 1978). The concept which emerges from the 
preceeding is that norepinephrine as well as other vasopressor 
substances stimulate arachidonic acid metabolism, resulting in 
the synthesis of prostaglandins which attenuate the pressor 
actions of the catecholamines. Thus, this stimUlation of 
arachidonic acid metabolism may be a factor in normal processes 
maintaining circulatory homeostasis which, when altered as in 
shock, may contribute to a failure of homeostasis and lead to 
microcirculatory collapse. 
The exact mechanism by which the catecholamine-induced 
increase in prostaglandin synthesis occurs is not well known. 
Levine and Moskowitz (1979) demonstrated a clear relationship 
between norepinephrine and stimulation of prostaglandin synthesis 
in canine kidpey cell cultures. This stimulation of synthesis 
could be blocked by a variety of alpha but not beta adrenergic 
receptor blocking agents, thus implicating alpha receptors in 
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this catecholamine induced stimulation of prostaglandin 
synthesis. By showing that synthesis of all arachidonic acid 
metaboli tes appeared to be equally increased by norepinephr ine, 
these investigators hypothesized that alpha receptor mediated 
stimulation occurred at the level of cyclooxygenation of 
~rachidonic acid or deacylation of phospholipids. Since 
?henoxybenzamine blocked only the stimulation of prostaglandin 
synthesis induced by norepinephrine, in contrast to arachidonic 
acid stimulation of prostaglandin synthesis, Levine and 
Moskowitz suggest that norepinephrine activates phospholipase A2 
via an alpha receptor mediated process to liberate arachidonic 
acid. 
In Summary 
1) Sympathetic activity increases in shock; 2) Thromboxane 
and prostacyclin synthesis increases during shock in both of the 
shock models described. These two models differ in the pattern 
of release of thromboxane and prostacyclin. The endotoxin model 
is characterized by a very low PGI2/TxA2 ratio in early phase of 
shock which is reversed in the later phases, while the fecal 
peritonitis (septic) model is characterized by a high PGI2/TxA2 
ratio throughout the entire Course -of shock; and~3) Sympathetic 
activity affects vascular tone and prostaglandin synthesis with 




The objective of this study is to evaluate potential inter-
actions between alpha adrenergic activity and prostaglandin 
synthesis in the pathophysiology of endotoxemia and septicemia. 
HYPOTHESES 
I) Increased activity of alpha adrenergic neurons plays a 
role in modulating thromboxane A2 (TxA2) and 
prostacyclin (PGI 2 ) synthesis in endotoxic and septic 
shock. 
II) The different patterns of release of arachidonic acid 
metabolites in these two forms of shock will provide a 
rationale for therapeutic intervention designed to block 
either or both the arachidonic acid cascade or the 
activity of the adrenergic nervous system. 
These hypotheses will be examined through experiments with 
the following specific aims: 
SPECIFIC AIMS 
1) To assess the effects of alpha receptor blockade with 
phenoxybenzamine (POB) in endotoxic shock and shock resulting 
from acute intra-abdominal peritonitis with regard to: 
a) Survival time and mortality 
b) Plasma iTxB2 and i6-keto-PGFla (stable immunoreactive 
metabolites of TxA2 and PGI2). 
c} Indices of shock severity, which include indicators of 
hepatocellular dysfunction and lysosomal labilization, 
hematocrit, platelet and leukocyte counts. 
2) To determine if the plasma levels of thrornboxane and 
prostacyclin, as seen in the two different shock models, can be 
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used to dictate which therapeutic interventions (POB and/or 
indomethacin) are most effective. 
3) To determine if inhibitors of a!pha adrenergic activity, 
such as POB, serve as a beneficial adjunct to therapeutic 
intervention with cyc!ooxygenase inhibi tors, i.e., indomethacin 
(INDO) • 
4) To determine the effects of POB and INDO on various 
cardiovascular parameters including mean arterial pressure, heart 
rate, and mean arteria! pressure response to injected 
norepinephrine in normal and endotoxin-treated rats. 
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CHAPTER TWO 
THE EFFECTS OF ALPHA ADRENERGIC BLOCKADE ON ARACHIDONIC 
ACID METABOLISM AND SHOCK SEQUELAE IN ENDOTOXEMIA 
INTRODUCTION 
Increased activity of the sympathoadrenal system occurs in 
endotoxin shock, as demonstrated by both elevated plasma levels 
and tissue depletion of catecholamines (Pardini et ale 1982; 
Jones and Romano, 1984). The alpha adrenergic receptor blocker 
phenoxybenzamine has also been shown to improve survival in both 
endotoxic and septic shock (Lillihei et al.1972; Filkins, 1979). 
In addition to sympathoadrenal activation, plasma levels of 
arachidonic acid metabolites are elevated in endotoxin shock 
(Fletcher and Ramwell, 1980a; Bult and Herman, 1982; Cook et 
al.1984). Studies with cyclooxygenase inhibitors or selective 
thromboxane (Tx) synthetase inhibitors have implicated TxA21 a 
potent vasoconstr ictor and platelet ag9regator and prostacyclin 
(PGI 2 ), a potent vasodilator and inhibitor of platelet 
aggregation, in the development of certain sequelae of 
endotoxemia and sepsis. Both increased adrenergic activity and 
arachidonic acid metabolism during endotoxin shock may therefore 
be significant factors modulating vascular tone and organ blood 
flow in shock. 
It is now apparent that there is a complex interaction 
between catecholamines and prostaglandins. Nor~pinephrine has 
been shown to stimulate the release of prostaglandins from 
tissues such as the kidney (Needleman et al., 1974; Dunn et 
al.1978), heart (Needleman and Kaley, 1978), and blood vessels 
(Grodzinska and Gryglewski, 1980). Eicosanoids have also been 
reported to affect catecholamine release (Malik, 1978). 
Stimulation of arachidonic acid metabolism by catecholamines may 
thus be a normal component of the processes maintaining 
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circulatory homeostasis, and an imbalance in these systems during 
shock may contribute to circulatory collapse. 
These observations prompted the present study of the effects 
of alpha adrenergic blockade on arachidonic acid. metabolism in 
endotoxic shock. Specifically, the effect of phenoxybenzamine on 
survival time and mortality, TxA2 and PGI2 synthesis, and on 
shock severity was determined (Specific Aim 1). The relative 
protective efficacy of phenoxybenzamine and indomethacin in 
single and conjoint therapy on these parameters was also compared 
(Specific Aims 2 + 3). 
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METHODS AND MATERIALS 
Male Long-Evans rats (220-390) were housed in plastic cages 
and maintained under conditions of constant temperature and 
controlled illumination (12: 12: light: dark). Water was ad 
libitum as was food (Wayne Feeds; Allied Mills, Inc. 
Libertyville, Ill). Food contained a minimum of 24% protein, 4.5 
% fiber, and 7% fat. Fats were 36.66% linoleic acid, 2.45% 
linolenic acid, and 4.16% arachidonic acid (composition data 
supplied by the manufacturer). 
Induction of Endotoxin Shock 
Shock was induced by a single bolus of bacterial endotoxin 
(Boivin preparation of Salmonella enteritidis lipopolysaccharide; 
lot #105-25 Difco Laboratories) via the dorsal vein of penis 
during light ether anesthesia. An 8 mg/kg dose was used for the 
studies to assess shock severity as well as survival time and 
mortality. A higher dose, 15 mg/kg, was used in experiments in 
which iTxB2 and i6-keto-PGF, a were measured (vide infra). This 
dose was chosen to increase the severity of shock and thus 
maximize the potential differences in these metabolite levels 
between the treatment groups. 
Treatment Protocol 
Phenoxybenzamine Hel (Smith, Kline and French) was freshly 
prepared in 30% ethanol and isotonic saline and administered 
intravenously at a dose of 1 mg/kg. In separate experiments 
(unpublished) mean arterial pressure responses to 0.02, 0.2, and 
2.0 mg/kg norepinephrine were studied. Three time points were 
examined: 1} 0.5 hi 2) 1 hi and 3) 4.5 h post-phenoxybenzamine 
1 3 
(corresponding to 0 min, 30 min, and 4 h post endotoxin in 
shocked animals, respectively. One mg phenoxybenzamine/kg body 
wt. resulted in a greater than 60% reduction in the vasopressor 
response to norepinephrine at all three time points in both 
shocked and unshocked animals (P<O.05). These data demonstrated 
significant (P<O.OS) alpha receptor blockade with this dose, and 
did not exacerbate the hypotension observed in shock (P>O.05). 
The cyclooxygenase inhibitor indomethacin was freshly 
prepared in sodium phosphate (O.1M) (pH 8.0) and administered 
intravenously (1 0 mg/kg). This dose has been shown in our 
laboratory to result in complete blockade of arachidonic acid 
metabolism by fatty acid cyclooxygenase in both normal and 
shocked rats (Cook et al., 1984). 
Survival Time and Mortality 
Rats were pretreated with indomethacin and phenoxy-
benzamine, singly or conjointly, 30 minutes prior to endotoxin 
injection (8 mg/kg). Determination of survival time was made by 
observation as the rat progressed through a characteristic series 
of symptoms including lethargy, tachypnea, loss of righting 
reflex, convulsions, and respiratory arrest. 
Parameters Used to Assess Shock Severity 
Rats were pretreated with ei ther phenoxybenzamine, (1 
mg/kg), indomethacin (10 mg/kg), or vehicle 30 minutes prior to 
endotoxin (8 mg/kg). Four hours post-endotoxin, blood samples 
were collected from the inferior vena cava for the various 
analyses. 
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Plasma beta-glucuronidase (BG) activity was measured 
colorimetrically by modification of the procedure of Fishman et 
ale (1967). Plasma aspartate aminotransferase (AST) was measured 
calorimetrically (Sigma chemical bulletin No. 509). Blood 
glucose was determined on freshly drawn blood using Dextrostix 
reagent strips with an Ames reflectance colorimeter (Ames 
Division, Miles Laboratories, Inc.). Hematocrit was determined 
by the micro method. 
Radioimmunoassay of immunoreactive (i) iTxB2 and i6-keto-PGFla 
Rats were pretreated with either phenoxybenzamine or a 
vehicle solution 30 minutes pr ior to injection of endotoxin (15 
mg/kg). At 30 minutes and 4 hours post-endotoxin, approximately 
5 ml of blood was collected from the inferior vena cava into 
plastic syringes containing 0.1 ml of indomethacin-heparin 
solution (2 mg of indomethacin; 5000 U of heparin dissolved in 
one ml of 0.1 ml sodium phosphate buffer, pH 8.0). Plasma 
immunoreactive (i) "iTxB2 and i6-keto-PGFla were measured using 
previously described radioimmunoassays (Burch et al., 1979; Wise 
et al.1980). Blood was centrifuged (1500 x g) for 20 mins, and 
the plasma collected and frozen at -20 oC until extraction. The 
... :0:-
minimal detectable amount of iTxB2 and i6-keto-PGFla in 1 ml of 
plasma was approximately 200 pg. Neither indomethacin nor 
phenoxybenzamine demonstrated cross reactivity in either 
radioimmunoassay. 
STATISTICAL ANALYSIS 
Indicators of shock severity were examined by analysis of 
variance-completely random design (ANOVA-CRD). The Newman-Keuls 
15 
test was used to examine differences between treatment groups. 
Geehan's Generalized Wilcoxon Test (Knapp and Wise,1985) was used 
for the surv i val tirne/mortali ty studies, and the unpai red 
Student's t-test was used for examining differences in eicosanoid 
concentrations between two treatment groups. All data were 
expressed as mean + standard error of the mean and confidence 
limits were set at 95% for significance. 
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RESULTS 
Plasma Arachidonic Acid Metabolites 
Previous studies have demonstrated non-detectable levels of 
iTxB2 and i6-keto-PGF1a in rats prior to induction of endotoxic 
shock (Cook et al., 1984; Wise et al., 1980). Rats receiving 
vehicle and admi ni ste red endotox in (1 5 mg/kg) e xhi bi ted plasma 
iTxB2 levels of 1532 + 319 pg/rnl at 30 minutes post-endotoxin, 
and 1131 + 135 pg /ml at 4 hou r s (F i g 3). Phenoxybenzamine 
pretreatment signif icantly (P<O.O 5) blunted the elevated plasma 
iTxB2 to 719 + 114 pg/ml at 30 minutes post-endotoxin 
(approximately 40% reduction). However, at 4 hours, iTxB2 
concentrations in the phenoxybenzamine treatment group were not 
different from the vehicle group (P>0.05). 
There was no difference in plasma concentrations of i6-keto-
PGFla demonstrated between the controls (811 + 108 pg/ml) and the 
phenoxybenzamine (615 + 93 pg/ml) group at 30 minutes after 
endotoxin administration (Fig 4). However, at 4 hours post-
endotoxin, the plasma concentrations of i6-keto-PGF 1a in the 
phenoxybenzamine group were only 30% of those of the controls 
(P<O.05 ). Plasma i6-keto-PGF1a was 1184 + 363 pg/ml in the 
phenoxybenzamine pretreated group compared to the untreated group 
mean of 4161 + 885 pg/ml. 
Survival Time and Mortality 
Pretreatment with vehicle 30 minutes before endotoxin 
challenge (8 rng/kg) resulted in a 77% mortality (LD 80) with a 
mean survival time of 9.5+1.8 hours (F ig 5). By contrast, 
indomethacin pretreatment resulted in a significant reduction in 
1 7 
Fig 3. Plasma iTxB2 concentrations during endotoxin shock. POB 
(1 mg/kg) or POB vehicle (CONTROL) was administered 30 
minutes before i.v. administration of S. enteritidis 
endotoxin (15 mg/kg). Plasma samples for iTxB2 were 
collected at 0.5 and 4 hrs post-endotoxin. Bars 
represent mean + SEM 
( ) = Number of rats. 
* p < 0.05 compared to controls. 
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Fig 4. Plasma i6-keto-PGF1a concentrations during endotoxin 
shock. POB (1 mg/kg) or POB vehicle (CONTROL) was 
administered 30 minutes before i.v. administration of s. 
enteritidis endotoxin (15 mg/kg). Plasma samples for 
i6-keto-PGFla were collected at 0.5 and 4 hrs post-
endotoxin. Bars represent mean + SEM ( ) = 
Number of rats. 
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Fig 5. Percent survi val in rats subjected to endotoxin shock. 
Rats were pretreated with indomethacin (INDO; 10 mg/kg), 
INDO vehicle, phenoxybenzarnine (POB; 1 mg/kg), POB 
vehicle, or INDO and POB (I + P) i.v. 30 minutes before 
~ enteritidis endotoxin (8 mg/kg). CONTROL = unshocked 
controls. Bars represent percent survival ( ) = Number 
of rats. 
* = p < 0.05 compared to controls.:: 
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mortality to 36%, and an increase in mean survival time to 
18.2+6. 1 hours (P<O.O 5 ). Pretreatment with phenoxybenzamine 
reduced mortality to only 12% in response to endotoxin (p<O.05). 
The combination of phenoxybenzamine and indomethacin decreased 
mortality to 9%. No significant differences were observed 
between the indomethacin, phenoxybenzamine, and phenoxybenzamine 
+ indomethacin treatment groups (P>O.OS). 
Indices of Shock Severity 
Rats given 8 mg/kg of endotoxin and vehicle exhibited the 
follow ing at four hours post-endotoxin: hypoglycemia, elevated 
hematocrit, and increased plasma levels of AST and BG. (Tables 
1-2). Indomethacin prevented only the hypoglycemia (p<O.05). 
Pretreatment with phenoxybenzamine resulted in significant 
improvement (P<O.OS) in the hypoglycemia and hemoconcentration. 
Treatment with indomethacin or phenoxybenzamine alone had no 
significant effect on plasma AST or BG. 
Treatment with the combination of phenoxybenzamine and 
indomethacin 30 minutes before endotoxin resulted in improvement 
of blood glucose, plasma AST, BG, and hematocrit. For each of 
the indicators of shock severity, no signifi~ant difference 
between pretreatment with phenoxybenzamine and pretreatment with 
the combination of phenoxybenzamine and indomethacin was observed 
(P>O.05). However, conjoint administration of phenoxybenzamine 
and indomethacin provided more protection than either agent used 
alone as suggested by the greater number of indices of shock 
severity in which a significant improvement occurred. 
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TABLE I 
Effects of Phenoxybenzamine (POB) and Indomethacin (INDO) 
Pretreatment on Hypoglycemia and Alterations in Plasma 
AST Induced by Endotoxin 
Group Blood Glucose Plasma AST 
(mg%) (S.F. Uni ts/ml) 
Control + Endotoxin 23 + 8 (4 ) 580 + 134 ( 4 ) - -
INDO + Endotoxin 73 + 8 (5)* 324 + 101 (5 ) - -
POB + Endotoxin 64 + 20 (4)* 224 + 37 ( 4 ) - -
POB + INDO + Endotoxin 101 + 5 (4)* 174 + 9 (9) * - -
Data expressed as mean + S.E. (N) 
INDO (10 mg/kg), INDO vehicle, POB (1 mg/kg), and/or POB 
vehicle were administered 30 minutes before S. enteritidis 
end 0 to x i n (8 m 9 /k 9 , i. v. ) • 
Samples were collected 4 hrs post-endotoxin. 
* P<O.05 compared to control + endotoxin 
TABLE II 
Effects of Phenoxybenzamine (POB) and Indomethacin (INDO) 
Pretreatment On Alterations In Hematocrit 
and Plasma Beta-Glucuronidase (BG) Induced by Endotoxin 
Group 
Control + Endotoxin 
INDO + Endotoxin 
POB + Endotoxin 
Hematocrit 
(%) 
53 + 1 (4) 
46 + 1 (5) 
43 + 4 (4)* 
POB + INDO + Endotoxin 40 + l (1)* 
-/ 
)/ 
Data expressed as mean~.E. (N) 
Plasma BG 
(units/ml) 
499 + 145 (4 ) -
168 + 27 (5 ) -
237 + 82 (4 ) -
130 + 18 (4 ) * -
INDO (10 mg/kg), INDO vehicle, POB (1 mg/kg), and/or POB 
vehicle were administered 30 minutes before S. enteritidis 
end 0 t 0 x i n (8 m 9 /k 9 , i. v • ) • 
Samples were collected 4 hrs post-endotoxin. 
* P<O.05 compared to control + endotoxin 
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DISCUSSION 
Nickerson and Carter (1959) were among the first to propose 
the use of phenoxybenzarnine as an anti-shock agent. However, the 
use of vasodilators such as phenoxybenzarnine in septic shock, as 
well as other forms of shock, has been controversial (Abrams et 
al.1969; Brake et al., 1964). The rationale for their use has 
been the prevention of ischemic vasoconstr iction, thereby 
maintaining flow despite the potential for further hypotension. 
By sustaining the match between tissue metabolism and perfusion, 
vasodilators may therefore prevent the ischemia which leads to 
increased capillary permeability, vasodil~ subsequent 
loss of blood volume and blood pressure (Lillihei, 1979). 
Salutary actions of phenoxybenzamine in endotoxin shock include 
metabolic as well as hemodynamic influences as indicated by a 
study in which alpha adrenergic blockade was associated with 
decreased hypoglycemia and enhanced gluconeogenesis during 
endotoxernia (Filkins, 1979). 
This study demonstrates that pretreatment with phenoxy-
benzarnine and indomethacin are individually protective in shock 
induced by an LDao dose of endotoxin as shown by improvement in 
survival and indicators of shock severity. Although indices of 
severity showed no significant differences between the 
indomethacin and phenoxybenzamine treatment groups, the 
combination of these drugs reduced more shock severity parameters 
than either drug alone. 
Our results agree, in part, with the previous report of Goto 
et al (1980) that indomethacin may make a significant 
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contribution as an antishock agent when perip~eral circulation is 
maintained, as with phenoxybenzamine. It ~s suggested that 
indomethacin, by inhibiting prostaglandin synthesis, may 
potentiate vascular reactivity to catecholamines during endotoxin 
shock, thus increasing vascular resistance and accelerating cell 
damage. Chapnick et al., (1976) and Gryglewski and Kobut (1975) 
in studies of the feline kidney and rabbit ear have reported that 
prostaglandin synthesis moderates the vasoconstrictor action of 
norepinephrine. Hall and Hodge (1971) have also presented data 
suggesting that cyclooxygenase inhibition potentiates the 
response of catecholamines in endotoxic shock. By contrast, 
Feuerstein et a1.(1981) demonstrated that the beneficial action 
of indomethacin in endotoxic shock is associated with reduced 
plasma elevations of norepinephrine and epinephrine. It was 
concluded in the latter study that the superior hemodynamic state 
in indomethacin-protected cats challenged with endotoxin resulted 
in a reduced stimulus for sympathetic stimulation. More 
recently, Fink et ale (1985) have demonstrated diminished 
sensitivity to norepinephrine and angiotensin II in the septic 
rat which is restored toward normal by indomethacin. They 
suggested that this decreased pressure responsiveness is mediated 
by vasodilating prostaglandins released during sepsis. 
It is now apparent that arachidonic acid metabolites have 
both facilitatory and inhibitory modulating effects on adrenergic 
neurotransmission. For example, prostaglandins of the F series 
enhance vascular reactivity produced by sympathetic stimulation, 
as well as the release of catecholamines from the adrenal medulla 
(Brody and Kadowitz,1974). The prostaglandin endoperoxide 
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analog, U-46619, and the TxA2 mimetic, carbocyclic TxA21 also 
potentiate responses to norepinephrine in vascular muscle tissue 
and rat anoccygeus muscle (Makita, 1983; Timimi et al., 1978). 
By contrast, prostaglandins of the E series inhibit adrenergic 
nerve transmission (Malik, 1978; Timimi et a1., 1978; Hedqvist, 
1977). Hedqvist (1977) reviews the large number of tissues where 
PGE's are potent inhibitors of neurally released NE release, and 
suggests a local PGE-mediated feedback mechanism. As suggested 
by both this investigator and the preceeding, arachidonic acid 
metabolites either inhibit or facilitate adrenergic neurotrans-
mission depending on the eicosanoid predominantly synthetized and 
its level of synthesis. 
Reductions in both iTxB2 at 0.5 hrs after endotoxin and i6-
keto-PGF1a at 4 hours post-endotoxin occurred after pretreatment 
with phenoxybenzamine (approximately 40% and 70%, respectively). 
Whether this is a result of a direct effect on arachidonic acid 
metabolism or is a nonspecific response to a reduction in shock 
severity remains to be determined. Previous in vitro studies, 
however, have demonstrated phenoxybenzamine-mediated reduction of 
prostaglandin synthesis b·y rat peri toneal nl'acrophages in response 
to norepinephrine and endotoxin (Tempel et al., 1984), and by 
Madin-Darby canine kidney cells in response to norepinephrine 
(Levine and Moskowitz, 1979). One must also consider the 
possibility that phenoxybenzamine may have acted to delay rather 
than suppress the elevations in iTxB2 and i6-keto-PGFla. 
In conclusion, our results suggest that a salutary action of 
phenoxybenzamine during endotoxic shock may be mediated, in part, 
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by a reduction of arachidonic acid metabolism in addition to 
attenuating the expression of alpha adrenergic activity. The 
improvement in more indices of shock severity following conjoint 
phenoxybenzamine and indomethacin treatment also suggests that 
cyclooxygenase inhibitors may be an effective adjunct with alpha 
adrenergic blockade in endotoxin shock. 
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CHAPTER THREE 
THE EFFECTS OF PHENOXYBENZAMINE AND INDOMETHACIN ON MEAN 
ARTERIAL PRESSURE, HEART RATE, AND MEAN ARTERIAL PRESSURE 
RESPONSE TO INJECTED NOREPINEPHRINE IN NORMAL AND ENDOTOXIN 
-TREATED RATS 
INTRODUCTION 
Initial studies of alpha receptor blockade with 1 mg/kg 
phenoxybenzamine (POB) in endotoxin shock in the rat have shown 
decreased shock severity, improved survival time, and attenuated 
levels of iTxB2 and i6-keto-PGFla ' the stable immunoreactive (i) 
metabolites of thromboxane and prostacyclin, respectively. These 
investigations raised the following questions: 1) What degree 
of alpha receptor blockade is effected by this dose?; 2) Does 
endotoxin influence the degree of receptor blockade?; and 3) 
What is the influence of POB on mean arterial pressure and heart 
rate over the course of shock in our rat endotoxin model? 
Similar questions arise regarding the effect of indomethacin 
(INDO) pretreatment (10 mg/kg) on mean arterial blood pressure 
and heart rate over the course of shock in our endotoxin model. 
With increased sympathetic activity during endotoxin shock 
(Pardini et al., 1982), INDO may alter mean arterial blood 
pressure response to catecholamines by removing the inhibitory 
influence of prostacyclin and/or other eicosanoids. Gullner et 
al., (1983 review) report that observations of the interaction 
between prostaglandins and the adrenergic nervous system are 
conflicting. !..n vit!:o, prostaglandin"s generally inhibit 
norepinephrine release and adrenergic neurotransmissioni in vivo, 
they appear to promote the release of norepinephrine. The basis 
for these conflicting results is unknown. These investigators 
suggest that the physiologic significance of the inhibitory 
actions of prostaglandins on transmitter release observed in 
vitro may apply only in states of increased sympathetic activity. 
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The purpose of this phase of the the study is: 1) To 
characterize the extent of alpha receptor blockade in unshocked 
and shocked animals; 2) To determine the influence of POB (1 
mg/kg) and INDO (10 mg/kg) on mean arterial blood pressure and 
heart rate over the course of shock; and 3) To examine the 
influence of INDO on the mean arterial blood pressure responses 
to graded doses of norepinephrine in the rat model of bolus 
endotoxin shock (Specific Aim 4). 
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METHODS AND MATERIALS 
Animals 
(See methods and materials of Chapter Two) 
Surgery and Anesthesia 
Long-Evans rats were anesthetized with 200 mg/kg Ketamine 
HCI (Vetalari Parke-Davis, Morris Plains, NJ). A cervical 
midline incision was made, and the carotid artery and jugular 
vein were cannulated with polyethylene tubing (PE 50) for 
drug/endotoxin administration and recording of blood pressure and 
heart rate. 
Blood Pressure and Heart Rate Recording 
A Grass Model 7 oscillographic recorder (Quincy, MA) and 
Statham pressure transducer (model P23Dc, Puerto Rico) were used 
to monitor blood pressure and heart rate over the course of 
shock. The carotid catheter was connected to the pressure 
transducer, and blood pressure and heart rate were monitored. 
When a stable blood pressure was observed for a minimum of five 
minutes, experiments were begun. Mean arterial pressure (MAP) was 
obtained electronically. The heart rate (HR) was calculated at 
various intervals throughout the course of shock: immediately 
before POB, INDO, or "vehicle adminis'tration, 0 minutes 
(immediately before endotoxin administration), 30 minutes 
(immediately before Group A, NE challenge), and 4 hours post-
endotoxin (immediately before Group B, NE challengeisee Figure 
6 ) • 
POB, INDO and Endotoxin Administration 
The same protocol for administration of POB, INDO, and 
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Fig 6. Description of experimental protocol. Half of the rats 
were monitored to 30 minutes post-endotoxin and then 
subjected to norepinephrine (NE) challenge (Grp A). The 
other half were monitored to 4 hrs post-endotoxin and 
then challenged with NE (Grp B). Mean arterial pressure 
(MAP) was recorded immediately after phenoxybenzamine 
(POB), indomethacin (INDO), or vehicle (V) at - 30 mins, 
immediately before endotoxin (e) or vehicle (C) at 0 
mins, at 30 mins (immediately before NE challenge in Grp 
A rats), and at 1, 2, 3, and 4 hrs post-endotoxin 
(immediately before NE challenge in Grp B rats). Heart 
rate (HR) was recorded at all of the same time points as 
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endotoxin as for Chapter 2 was used with the following 
exceptions: injections were via the jugular cannula rather than 
the dorsal vein of the penis and 20 mg endotoxin/kg was used. 
See Table III for description of groups used in these 
experiments. 
Norepinephrine Challenge 
To determine the extent of alpha receptor blockade, the MAP 
response to three logarithmic doses of norepinephrine (NE) was 
examined at 30 minutes and 4 hours post-endotoxin. These time 
points were chosen to correlate with the iTxB2 peak at 30 mins 
post-endotoxin and the high i6-keto-PGF la levels seen at 4 hours 
post-endotoxin in our model (Cook et al., 1984). These were also 
the times at which plasma was collected for assay of iTxB2 and 
i6-keto-PGF1a in earlier experiments (Chapter 2). The 4 hours 
post-endotoxin time point was also used in the previous 
experiment (Chapter 2) to assess the degree of shock severity. 
Preliminary studies indicated the adequacy of the doses selected 
to produce graded increases in mean arterial pressure. The 0.02, 
0.2, and 2.0 mg/kg doses were given as a bolus injection starting 
with the lowest dose followed by an isotonic saline flush. After 
observing the peak MAP response within 5-15 seconds, the next 
dose was administered after the MAP returned to baseline levels. 
The NE solutions used were prepared from the bitartrate salt 
dissolved in a 0.9% saline solution. Dilutions from the stock 
solution were made, and aliquots of the three logarithmic doses 
were frozen. One hour before NE was administered, the solutions 
were allowed to thaw and warm to room temperature. 
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TABLE III 
Treatment Groups Used in Experiments 
Treatment Group 
Endotoxin vehicle + POB vehicle 
Endotoxin + POB 
Endotoxin + POB vehicle 
Endotoxin + POB 
Endotoxin vehicle + INDO vehicle 
Endotoxin vehicle + INDO 
Endotoxin + INDO vehicle 
Endotoxin + INDO 
Abbreviation 
= Grp C + V 
= Grp C + P 
= Grp E + V 
= Grp E + P 
= Grp C + V 
= Grp C + I 
= Grp E + V 
= Grp E + I 
The first four groups, C+V, C+P, E+V, and E+P were 
subdivided into Group A (monitored to 30 rnins post-
endotoxin and then challenged with NE) and Group B 
(monitored to 4 hrs post-endotoxin and then challenged 
with NE). The last four groups (INDO or INDO vehicle) 
were monitored only to 30 mins post-endotoxin before NE 
challenge. 
Endotoxin = E, Endotoxin vehicle = C, indomethacin = 




Differences in MAP and HR at selected time points of the 
experimental period and differences in MAP response to injected 
NE between the treatment groups were examined by analysis of 
variance-randomized complete block design (ANOVA-ReBD). All data 
are expressed as mean + standard error of the mean, and 
confidence limits were set at 95% for significance. 
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RESULTS 
Animals observed to 30 mins post-endotoxin = POB Group A 
Mean arterial pressure of the four groups did not differ at 
30 minutes prior to endotoxin administration, i.e., immediately 
before POB or vehicle injection (Fig. 7). Unshocked controls 
(Group C+V) exhibited a stable MAP over the experimental period 
(94 + 9 initially, 104 + 11 mm Hg at 30 mins post-endotoxin 
vehicle). Pretreatment with POB led to 30 and 22 mm 8g reduction 
of MAP from control values in C+V and E+V groups examined 
immediately prior to endotoxin, respectively. At 30 minutes 
post-endotoxin, the shocked animals, Groups E+V and E+P, 63 + 15 
and 59 + 7 respectively, had significantly lower pressures than 
the unshocked controls of Group C+V (94 + 9). There was, 
however, no significant difference (P>0.05) between Groups E+V 
and E+P, suggesting that POB did not exacerbate the endotoxin-
induced hypotension. 
There were no significant differences in HR between the four 
treatment groups at the time points observed except between POB-
treated animals subjected to endotoxin (Grp C+Pi Table IV) and 
unshocked controls (Grp C+ViTable IV). 
Animals subjected to NE challenge 30 minutes post-endotoxin 
or endotoxin vehicle (Fig. 8) showed a 22+ 8, 40 + 12, and 73 + 
10 mm 8g increase in MAP in response to 0.02, 0.2, and 2.0 mg/kg 
of injected NE. In contrast, POB pretreated animals showed 
approximately a 90% reduction in the response, 5 + 5, 5 +6, and 2 
+ 3, respectively (P<O.OS). Endotoxin-treated controls 
demonstrated approximately a 60% reduction in response to NE, 9 + 
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Fig 7. Mean arterial pressure at - 30 mins, 0 mins, and 30 mins 
post-endotoxin. Rats were pretreated with POB (1 mg/kg) 
or vehicle (V) 30 minutes S. enteritidis endotoxin (E; 20 
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TABLE IV 
Effects of POB and Endotoxin on Heart Rate in 
Rats Observed to 30 Minutes Post-endotoxin 
Group -30 mins o mins 30 mins 
Group C + V 334 + 28 335 + 32 322 + 32 
Group C + p 289 + 6 266 + 13 255 + 11 
Group E + V 331 + 30 323 + 41 355 + 10 
Group E + P 353 + 30 320 + 19 347 + 6** 
Data expressed as mean + S.E. 
Heart rate at - 30 mins, 0 mins, and 30 mins post-endotoxin. 
Rats were pretreated with POB (1 mg/kg) or vehicle (V) 30 mins 
before S. enteritidis endotoxin (Ei20 mg/kg) or vehicle (C). 
N=5 for-each group. 
** p < 0.05 (ANOVA) compared to rats treated with POB and 
endotoxin vehicle (Grp C+P). 
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Fig 8. Mean arterial pressure response to three logarithmic 
doses of NE (0.02, 0.2, and 2.0 mg/kg) at 30 mins post-
endotoxin. Rats were pretreated with POB (1 mg/kg) or 
vehicle (V) 30 mins before s. enteritidis endotoxin (Ei 
20 mg/kg) or vehicle (C). N = 5 for each group_ 
* P<0.05 (ANOVA) compared to controls. 
** P<0.05 (ANOVA) compared to controls and rats treated 





















D mean c+v 
~ meanc+p 
EJ ::;::: mean e+v 
rzJ .. mean e+p 
5, 15 + 6, and 43 + 18 (P<0.05). Shocked rats pretreated with 
POB (Group E+P) were significantly (P<0.05) reduced in response 
to NE compared to rats given endotoxin alone only at the 2.0 
mg/kg dose of NE. However, these animals exhibited a 
significantly lower MAP response at all three doses of NE, 
approximately an 85% reduction compared to the unshocked controls 
of Group C+V. 
Animals observed to ! hours post-endotoxin = POB Group B 
Mean arterial pressure examined at four hours post-endotoxin 
showed no significant difference (P>O.05) between the four 
treatment groups (F ig. 9). Unshocked controls, Group C+V, 
exhibited a stable MAP (91 + 8 and 98 + 15 mm Hg throughout the 
4.5 hour experimental period. Pretreatment with POB alone did 
not significantly reduce MAP in Group C+P animals either prior to 
or 30 minutes post endotoxin vehicle administration (78 + 4 and 
73 + 8 vs. 91 + 8 and 92 + 12, respectively). Endotoxin 
administration did not significantly reduce MAP in Groups E+V 
and E+P animals compared to unshocked controls. Mean arterial 
pressures of shocked rats treated with POB and endotoxin were not 
significantly different from animals given only endotoxin (Fig. 
9). POB did not therefore effect a reduction in blood pressure 
to values below those of respective unshocked and shocked 
controls. 
Heart rate in POB-treated rats given endotoxin (Grp E+Pj 
Table V) was significantly different (P<O.OS) from both unshocked 
controls (Grp C+V) and rats given only POB (Grp C+P) at 4 hours 
post-endotoxin. There were no other significant differences in 
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Fig 9. Mean arterial pressure at - 30 mins, 0 mins, 30 mins, 1 
hr, 2 hrs, 3 hrs, and 4 hrs post-endotoxin. Rats were 
pretreated with POB (1 mg/kg) or vehicle (V) 30 mins 
before s. enteritidis endotoxin (Ej 20 mg/kg) or vehicle 
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TABLE V 
Effects of POB and Endotoxin on Heart Rate in Rats 
Observed to 4 Hours Post-endotoxin 
Group -30 mins o mins 4 Hrs 
Group C + V 325 + 14 298 + 10 302 + 13 
Group C + p 313 + 23 261 + 25 322 + 32 
Group E + C 376 + 20 353 + 23 336 + 14 
Group E + P 368 + 32 292 + 18 399 + 14*** 
Data expressed as mean + S.E. 
Heart rate at - 30 mins, 0 mins, and 4 hrs post-endotoxin. 
Rats were pretreated with POB (1 mg/kg) or vehicle (V) 30 
min s be for e S • en t e r i tid i 5 end 0 t 0 x i n (E; 20m g /k g ) 0 r 
vehicle (e). N= 6 for each group. 
*** P <0.05 (ANOVA) compared to controls (C+V) and rats 
treated with only POB (C+P). 
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HR between the four treatment groups. 
Unshocked controls showed a 35 + 16, 45 + 12, and 85 + 9 mm 
Hg response to the increasing doses of NE at 4 hrs post-endotoxin 
(Fig 10). POB pretreatment alone (Group C+P) resulted in 
approximately a 65% reduction in the MAP response to three doses 
of NE (13 + 4,15 + 9, and 28 + 9 mm Hg). Endotoxin alone (Group 
E+V) resulted in a 40% reduction of the MAP response to all three 
doses, 9 + 9, 25 + 15, and 53 + 28, respectively (P<O.05). 
Shocked rats treated with POB showed a greater than 70% reduction 
in the MAP response to NE (3 + 3, 7 + 5, and 25 + 9 mm H9 
compared to control rats; (P<O.05). There was no significant 
difference in the response to NE of animals given endotoxin alone 
(Group E+V) and animals given POB and endotoxin (Group E+Pi 
(P<0.05). 
Animals observed to 30 mins post-endotoxin = INDO Group A 
The unshocked controls, Groups C+V (Fig. 11), exhibited a 
stable MAP of approximately 100 mm 89 over the 1.5 hour 
observation period. Pretreatment with the cyclooxygenase 
inhibitor, INDO, did not significantly alter MAP. Endotoxin 
resulted in a decrease in MAP at 30 mins post-endotoxin in Groups 
E+V and E+I compared to unshocked controls (72 + 12 and 78 + 12 
vs. 97!. 8 and 85 + 12 mm Hg). 
Neither INDO nor endotoxin had any effect on HR. No 
significant differences were observed between any of the four 
treatment groups at the three time points (Table VI). 
Unshocked controls exhibited a dose-response increase in 
response to NE similar to the previous experiment (20 + 10, 37 !. 
30 
Fig 10. Mean arterial pressure response to three logarithmic 
doses of NE (0.02, 0.2, and 2.0 mg/kg) at 4 hrs post-
endotoxin. Rats were pretreated with POB (1 rng/kg) or 
vehicle (V) 10 mins before S. enteritidis endotoxin (Ei 
20 mg/kg) or vehicle (C). N = 6 for each group. 
* P<0.05 (ANOVA) compared to controls. 
** P<O.05 (ANOVA) compared to controls and rats treated 
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Fig 11. Mean arterial pressure at - 30 mins, 0 mins, and 30 mins 
post-endotoxin. Rats were pretreated with INDO (10 
mg/kg) or vehicle (V) 30 minutes before s. enteritidis 
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TABLE VI 
Effects of INDO and Endotoxin on Heart Rate in 
Rats Observed to 30 Minutes Post-endotoxin 
Group -30 mins o mins 30 mins 
Group C + V 353 + 25 347 + 24 330 + 29 
Group C + p 346 + 21 319 + 16 291 + 21 
Group E + V 323 + 25 339 + 24 294 + 7 
Group E + P 344 + 28 329 + 20 279 + 17 
Data expressed as mean + S.E. 
Heart rate at - 30 mins, 0 mins, and 30 mins post-endotoxin. 
Rats were pretreated with INDO (10 mg/kg) or vehicle (V) 30 
mins before S. enteritidis endotoxin (Ei 20 mg/kg) or 
vehicle (C). N= 6 for each group. 
3ue 
Fig 12. Mean arterial pressure response to three logarithmic 
doses of NE (O.02, 0.2, and 2.0 mg/kg) at 30 minutes 
post-endotoxin. Rats were pretreated with INDO (10 
mg/kg) or vehicle (V) 30 mins before S. enteritidis 





0 mean c+v I 












0.02 0.2 2.0 
Norepinephrine (mg/kg) 
30g 
13, and 71 + 8 mm Hg, respectively; Fig. 12). Pretreatment with 
INDO had no effect on the response to NE (P>0.05). In contrast 
to the earlier results, the endotoxin-induced attenuation of the 
MAP response to NE was not found at any of the three doses of NE 
(17 + 4,30 + 7, and 72 + 7 mm Hg). INDO pretreatment failed to 
alter the response of shocked animals to NE compared to shocked 
controls (13 + 10,28 + 7, and 73 2: 12 mm Hgi P>O.05). Because 
of the lack of influence of INDO on hemodynamic parameters and 
response to NE in animals observed to 30 mins post-endotoxin, no 
effort was made to extend these studies to four hours post-
endotoxin. 
Summary 
1. POB leads to a reduction in MAP in unshocked rats, but does 
not significantly exacerbate endotoxin-induced hypotension. 
2. Administration of 1 mg/kg POB effected a 60-90% reduction in 
the MAP response to injected NE in shocked and unshocked 
animals, respectively. 
3. Endotoxin alone resulted in a 40%-60% reduction in the 
magnitude of the MAP response to injected NE compared to 
controls. 
~ 
4. INDO pretreatment has no significant effect on MAP or HR at 
any of the three time points observed up to 30 mins post-
endotoxin in unshocked and shocked rats. INDO also did not 
significantly affect the MAP response to injected NE. 
5 • POB and endotoxin, given individually, did not 
significantly affect HR at the time points up to 4 hrs post-
endotoxin. Endotoxin administration in POB-pretreated rats 
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resulted in a significant increase in HR compared to rats 
given only POB at 30 mins post-endotoxin, and to both 




The use of vasodilators such as POB in septic shock, as well 
as other forms of shock, has been fraught with controversy 
concerning their efficacy (Abrams et al., 1969; Brake et al., 
1964). The rationale for the use of vasodilators is that despite 
the potential for further hypotension, by preventing excessive 
vasoconstriction they maintain tissue perfusion. By effecting a 
better match between tissue metabolism and perfusion, 
vasodilators thus prevent the ischemia leading to increased 
capillary permeability, vasodilation, and subsequent loss of 
blood volume and blood pressure (Lillihei, 1979). 
Previous experiments (Chapter 2) have suggested that an 
additional beneficial effect of POB is the attenuation of the 
synthesis of arachidonic acid metaboli tes, thromboxane and 
prostacyclin, which have been implicated in pathophysiology of 
endotoxin shock (Cook et al., 1984). 
Results of these experiments suggest that the 1 mg/kg dose 
of POB effected a 60-90% reduction in the MAP response to 
injected NE in both control animals and animals subjected to 
endotoxin. Although the administration of POB to unshocked rats 
resulted in depression of MAP in some instances compared to 
unshocked controls, this dose did not increase the endotoxin-
induced hypotension, a potential cardiovascular side effect that 
may have contraindicated the use of POB. 
The MAP response to NE was not completely suppressed 
suggesting that not all alpha receptors were saturated. This 
dose was, however, sufficient to significantly suppress the 
production of iTxB2 and i6-keto-PGF1a ' resulting in decreased 
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shock severity and increased survival time. In addition to the 
experimental use of different animals and shock models, 
variations in the dose and time of drug administration may also 
be important determinants of the outcome (Skjoldburg, 1968). 
Preliminary work in our laboratory suggests that POB has no 
salutary actions in a fecal peritonitis model of septic shock 
(Chapter 4). This model, in contrast to the endotoxin model, is 
characterized by a high prostacyclin/thrornboxane ratio over most 
of the course of shock (Cook et al., 1984); Butler et al., 1982). 
Since prostacyclin is a potent vasodilator and thromboxane is a 
potent vasoconstrictor, vasodilators such as POB may be 
contraindicated in shock states characterized by such a ratio of 
arachidonic acid metabolites. 
The endotoxin-induced attenuation of the MAP response to 
injected NE (Figs 8, 10, and 12) is consistent with other reports 
in the literature, and various mechanisms have been proposed to 
explain this depression of vascular reactivity. Manson and Hess 
(1983) postulated that endotoxemia results in the release of 
oxygen free radicals which then result in depressed contractility 
in cardiac muscle and depressed reactivity of vascular smooth 
muscle. Soulsby et. ale (1980) support this hypothesis by 
demonstrating depressed canine aortic microsome calcium uptake 
rate during endotoxin shock as a result of a parallel depression 
in membrane bound calcium stimulated ATPase activity. Fink et. 
a1. (1980) using a cecal ligation rat sepsis model showed a 
diminished pressor response to both NE and angiotensin II in 
septic rats. Since responsiveness was restored toward normal in 
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animals pretreated with indomethacin, these investigators 
concluded that this phenomenon of diminished responsiveness may 
be mediated by vasodilating prostaglandins, i.e., prostacyclin 
and PGE2. McM illan and Roth (1 986) also using a cecal ligation 
rat model demonstrated a decrease in hepatic alpha 1 adrenergic 
receptors following sepsis. They suggested that decreased 
vascular responsiveness in sepsis may be a result of alterations 
in alpha 1 receptor number or receptor-effector coupling. 
Chernow and Roth (1986) in a review article cite, in addition to 
some of the mechanisms discussed above, the role of endogenous 
opoid peptides which may impair normal adrenergic function during 
shock. This possibility is supported by experiments in which 
opiate antagonists such as TRH has been shown to transiently 
increase vascular resistance in hemorrhagic shock (Siren et. 
al., 1986). 
The data suggest that endotoxin administration in rats 
pretreated with POB have significantly higher heart rates than 
rats given only POB at 30 mins post-endotoxin (Table IV), and 
both unshocked controls and rats given only POB at 4 hrs post-
endotoxin (Table V). Since there were no other significant 
differences in HR between the four- treatments grbups at the time 
points observed, the physiological significance of these findings 
is not clear. 
The lack of significant differences in mean arterial 
pressure in animals observed to four hrs post-endotoxin (Fig. 9), 
in contrast to the group observed to 30 mins post-endotoxin, may 
indicate an inadequate response in animals given only endotoxin. 
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However, this lack of differences in mean arterial pressure could 
represent transient normalization of blood pressure via 
compensatory mechanisms which then eve~tually fail to maintain 
pressure at a time point beyond the experimental period. The 
anesthesia and surgical stress of catheterization may also have 
rendered the rats more resistant to the influence of endotoxin. 
The cyclooxygenase inhibitor, indomethacin, failed to affect 
the MAP response to NE as we 11 as MAP and 8R over the course of 
shock. The dose of INDO used (10 mg/kg) has been previously 
shown to almost completely suppress the synthesis of thromboxane 
and prostacyclin in our laboratory (Cook et al., 1984). Tempel 
et al., (1982) demonstrated the pretreatment with 10 mg/kg INDO 
ameliorated endotoxin-induced reduction in cardiac output and 
blood flow to the heart, kidney, lung, liver, spleen, and GI 
tract in the rat. Similarly, Fletcher and Ramwell (1980b), in a 
baboon endotoxic shock model, showed a correlation in elevated 
thromboxane levels with the acute rise in pulmonary arterial 
pressure. Increased levels of 6-keto-PGF1a late in shock was 
correlated temporally with the decline in arterial pressure. 
Treatment with 1.5 mg/kg INDO one hour after endotoxin 
administration reversed both the alterations in ~he levels of the 
arachidonic acid metabolites and the corresponding hemodynamic 
sequelae. Goto et al., (1980) suggested inhibition of 
prostacyclin synthesis by INDO allows catecholarnines to act 
unopposed, i.e., augmenting the action of these vasoactive amines 
on the cardiovascular system. Their experiments demonstrated the 
lack of any effect of INDO on blood pressure, cardiac output, or 
left ventricular isometric tension rise in shocked, reserpine-
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treated, and adrenalectomized dogs. Alpha and beta blocking 
agents in these studies suppressed the high hemodynamic state 
induced by INDO treatment. Feuerstein et al., (1981) also report 
a improved hemodynamic status as a result of INDO administration 
in cat subjected to endotoxin. Their data, however, show a 
suppression of plasma epinephrine and norepinephrine as a result 
of INDO treatment. Similarly, INDO treatment of patients with 
Bartter's syndrome corrected the hypercatecholaminuria associated 
with this condition (Gullner et al., 1980). These patients have 
high levels of circulating prostaglandins, particularly PGE2 and 
PGI 2 , which are thought to have an inhibitory influence on 
sympathetic neurotransmission. As a result, these investigators 
suggest that the high levels of catecholamines in these patients 
are a result of compensation for a prostaglandin-mediated pressor 
resistance to norepinephrine. 
The lack of significant alterations in hemodynamic parameters 
and response to exogenous NE following treatment with INDO may be 
indicative of inadequate response to endotoxin. The finding of 
no reduction in response to NE in rats treated with only 
endotoxin in this last group of experiments supports this 
contention. 
In conclusion, the results of this study have described the 
influences of the alpha blocker POB (1 mg/kg) and the 
cyclooxygenase inhibitor INDO (10 mg/kg) on three hemodynamic 
variables in normal rats and rats subjected to endotoxin: mean 
arterial pressure, heart rate, and mean arterial pressure 
response to injected norepinephrine. Our results suggest that 
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the 1 mg/kg dose of POB provides adequate alpha receptor blockade 
without exacerbating the hypotension seen in endotoxin-treated 
rats or significantly influencing heart rate. INDO (10 mg/kg) 
did not appear to affect any of these three parameters in normal 
rats and endotoxin-treated rats. 
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CHAPTER FOUR 
THE EFFECTS OF ALPHA ADRENERGIC BLOCKADE ON ARACHIDONIC 
ACID METABOLISM AND SURVIVAL IN SHOCK INDUCED BY 
INTRAABDOMINAL SEPSIS 
INTRODUCTION 
Data from previous experiments (Chapter 2) suggest that 
pretreatment with 1 mg/kg of the alpha receptor blocker, POB, 
results in improved survival time, decreased mortality, decreased 
shock severity, and reduced plasma levels of iTxA2 and i6-keto-
PGFla in the rat bolus endotoxin model. Although the reductions 
in iTxB2 and i6-keto-PGFla effected by POB were significant, 
they were not complete, i.e., approximately 40% reduction in 
iTxB2 at 30 minutes post-endotoxin in and 70% reduction in i6-
keto-PGF la at 4 hrs post endotoxin. Some investigators have 
expressed the opinion that the absolute presence or absence of 
detectable levels of iTxB2 and i6-keto-PGFla is not as important 
as the ratio of these tissue autocoids in determining the 
efficacy of various pharmacologic agents in septic shock. Cook 
et al., (1984) proposed that the failure of selective thromboxane 
synthetase inhibitors to improve survival in a fecal peritonitis 
model of sepsis when improved survival was the result in the rat 
endotoxin model is due, in part, to different patterns in the 
plasma levels of iTxB2 and i6-keto-PGF1a over the course of 
shock (see Chapter 1 for description of models). In particular, 
selective thromboxane synthetase inhiBitors may be 
contraindicated in shock states characterized by high PGI2/TxA2 
ratios. 
These findings combined with the controversy concerning the 
efficacy of treatment with POB in various septic shock models 
(Abrams et al., 1969; Brake et al., 1964; Skjoldburg et al., 
1968), suggest that the underlying pattern of arachidonic acid 
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metabolites may dictate the therapeutic efficacy of alpha 
receptor blockade with POB in sepsis. 
The purpose of this study was to extend the results of 
treatment with POB in the rat bolus endotoxin model by assessing 
the effect of this alpha receptor blocker in a fecal peritonitis 
model of sepsis. Specifically, the effects of POB on survival 
time and mortality and on the synthesis of iTxB2 and i6-keto-
PGF la' the stable rnetaboli tes of thromboxane and prostacyclin, 
were examined (Specific Aim 1). The relative protective efficacy 
of POB and indomethacin (INDO) were also compared in single and 
conjoint therapy with respect to survival time and mortality 
(Specific Aims 2 + 3). 
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METHODS AND MATERIALS 
Animals 
(see Chapter 2 - Methods and Materials) 
Induction of Shock from Fecal Peritonitis Induced BY Intra-
Abdominal Injection of Feces 
Fecal peritonitis was induced by a single intraperitoneal 
injection of fecal suspension as described by Butler et al., 
(1982). The standard dose employed in this study was .74 gm dry 
weight/kg body weight, which has been used by Butler et ale to 
produce a mean survival time in the rat of 9.2 + 0.5 hrs with 
100% mortality within 48 hrs. 
Treatment Protocol 
Phenoxybenzamine HCI (Smith, Kline, and French) was freshly 
prepared in 30% ethanol and isotonic saline, and administered at 
a dose of 1 mg/kg body wt. Although the effects of this dose on 
mean arterial pressure and heart rate over the course of shock 
and on the mean arterial pressure response to injected 
norepinephrine has been studied in the bolus endotoxin model 
(Chapter 3), a similar study has not been done with the fecal 
peritonitis model of sepsis. 
The cyclooxygenase inhibitor INDO was freshly prepared in a 
sodium phosphate bufffer solution (ph 8.0) and administered 
intravenously (10 rng/kg body wt). This dose has been shown to 
result in effective blockade of arachidonic acid metabolism in 
both normal rats and rats subjected to fecal peritonitis (Butler 
et al., 1982). 
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Survival Time and Mortality 
Rats were pretreated with either INDO or POB, independently 
or conjointly, prior to challenge by intraperitoneal injection of 
feces (.74 gm dry wt/kg body wt). Determination of survival time 
was made by observation as the rats progressed through a 
characteristic series of symptoms including lethargy, tachypnea, 
loss of righting reflex, convulsions, and respiratory arrest. 
Radioimmunoassay of immunoreactive ill iTxB2 and i6-keto-
PGFla 
The methodology for this experiment is the same as described 
under Methods and Materials in Chapter 2, except that blood 
samples were collected at 1 hr and 6 hr post-intraperitoneal 
injection of feces rather than 0.5 hr and 4 hr post-endotoxin. 
These time points were selected to correlate with previous 
findings in our laboratory with this shock model concerning the 




Survival time and mortality were examined by analysis of 
variance-completely random design (ANOVA-CRD). The Newman-Keuls 
test was used to examine differences between treatment groups. 
The unpaired Student's t-test was used to test for differences in 
iTxB2 and i6-keto-PGFla between treatment groups. All data were 
expressed as mean + error of the mean and confidence limits were 
set at 95% for significance. 
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RESULTS 
Survival Time and Mortality 
In this model of sepsis, untreated control animals given 
vehicle 30 mins before intra-abdominal injection of feces 
exhibited 100% mortality within 48 hrs with a mean survival time 
of 9.2 + 0.3 hrs (Table VII). POB pretreatment appeared to 
depress survival time to 7.5 + 0.5 hrs and resulted in 100% 
mortality within 48 hrs. However, this group was not 
statistically different from controls (P)0.05). Pretreatment 
with INDO resulted in an improvement in mean survival time to 
20.2 + 1.4 hrs (p<O.05) compared to controls and to rats treated 
with only POB, but failed to alter mortality (100% within 48 
hrs). Pretreatment with the combination of POB + INDO failed to 
decrease mortality (100% within 48 hrs), but increased mean 
survival time to 23.7 + 2.2 hrs (P<O.05 compared to controls and 
to animals treated with only POB). There was no significant 
difference in survival time or mortality between rats treated 
with only INDO and rats treated with POB + INDO. 
Plasma Arachidonic Acid Metabolites 
Septic rats given vehicle alone exhibited~_ plasma iTxB2 of 
1184 + 719 pg/ml 1 hr post-injection, and 2004 + 368 pg/ml at 6 
hr after injection (Table VIII). Pretreatment with POB did not 
significantly (P>O.05) alter plasma levels of iTxB2 at 1 hr and 6 
hr post-injection compared to controls (434 + 135 pg/ml and 1749 
+ 747 pg/ml, respectively. 
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TABLE VII 
Effects of Phenoxybenzamine (POB) and Indomethacin (INDO) 
Pretreatment on Survival During Fecal Peritonitis (FP) Shock 
Group Mean Survival Time 
Control + FP 9.2 + 0.3 ( 10) -
INDO + FP 20.2 + 1 • 4 ( 1 4 ) * -
POB + FP 7.5 + 0.5 ( 9 ) -
INDO + POB + FP 23.7 + 2.2 ( 14 ) * 
* 
-
Data presented as mean + S.E. (N) 
P<O.05 compared to controls and rat treated with only POB 
Rats were pretreated with INDO (10 mg/kg). INDO vehicle. 
POB (1 mg/kg), POB vehicle or POB and INDO via I.V. 30 
minutes before intraperitoneal injection of feces (.74 gms 
dry wt/hg/body wt). There were no survivors after 48 hrs 
post-injection. Control = POB vehicle + INDO vehicle. 
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TABLE VIII 
Effect of Phenoxybenxamine (POB) on Arachidonic 
Acid Metabolites in Septic Shock 
Group 
1 Hour 
Control + FP 
POB + FP 
6 Hours 
Control + FP 
POB + FP 
iTXB2 
(pg/ml plasma) 
1184 + 719 (2 ) -
434 + 135 (3 ) -
2004 + 368 (3) 
1749 + 747 (2) 
6-keto-PGF la 
(pg/ml plasma) 
7554 + 1325 ( 4 ) -
7616 + 279 (3 ) -
10004 + 630 (3) 
6462 + 3227 (2) 
POB or POB vehicle (control) was administered i.v. (1 mg/kg) 
30 minutes prior to intraperitoneal injection of feces (.74 
9 dry wt/kg body wt). P las rna samples we re collected at 1 
hour and 6 hours post-injection. 
Data expressed mean + S.E. (N) 
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There was no significant difference in plasma concentration 
of i6-keto-PGFla between controls (7754 + 1325 pg/ml) and 
animals treated with POB (7616 + 279 pg/ml) at 1 hr post-
injection of feces (P>O.OS). SirrLilarly, no difference was 
observed in the POB group at 6 hrs compared to the vehicle group 
(10004 + 630 pg/ml vs 6462 + 3227). 
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DISCUSSION 
In contrast to the results observed with the rat bolus 
endotoxin model of sepsis, pretreatment with POB in the 
peritonitis model afforded no significant protection with regard 
to survival time and mortality. In this LD100 sepsis model, INDO 
pretreatment was clearly more beneficial in improving survival 
time than pretreatment with POB (P<O.05). In the bolus endotoxin 
model, both agents improved survival compared to controls with no 
significant difference between the two inhibitors. The data 
suggest that the combination of INDO and POB is more effective 
than POB alone; however, this combination was no better than INDO 
acting individually. The failure of POB to effect an improvement 
in survival in this model of sepsis may result as a consequence 
of the following: The levels of prostacyclin, a potent 
vasodilator, have been shown to be markedly elevated in fecal 
peritonitis shock. By contrast, the levels of thromboxane, a 
potent vasoconstrictor, are comparatively low (Butler et al., 
1 982 ). Furthermore, the synthesis of these arachidonic acid 
metabolites is not completely suppressed by pretreatment with 
POB, as suggested by the results with the bolus endotoxin model 
(Chapter 2) and the results of this study (vide supra). The 
prevailing plasma levels of these metabolites in this shock 
model, which indicate a high PGI2/Tx ratio, combined with the 
additional vasodilation effected by POB-induced alpha receptor 
blockade may intensify hypotension, and exacerbate the mismatch 
between perfusion and metabolism. 
There were no significant differences in plasma levels of 
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iTxB2 and i6-keto-PGFla between controls and rats treated with 
POB at either 1 hr or 6 hr after induction of intraabdominal 
sepsis. The variability in the response of the animals and the 
small number of rats in each group may have contributed to this 
lack of statistically significant differences. It is also 
possible that significant differences in arachidonic acid 
metabolite levels may have arisen beyond the experimental period. 
The mean plasma levels of iTxB2 in controls at 1 hr post-
injection (1184 pg/ml) was greater than 2.5 times that of the POB 
treated animals (434 pg/ml). Similarly, the mean levels of i6-
keto-PGFla in controls at 6 hrs post-injection (10004 pg/ml) is 
about 1.5 times that of POB-treated rats (6462 pg/ml). These are 
preliminary results which warrant further investigation to 
determine if significant differences do exist in a larger group 
of animals observed over a longer experimental period. Despite 
the lack of protection seen with POB with regard to survival 
time/mortality, demonstration of a POB-mediated reduction in 
iTxB2 and i6-keto-PGF1a in this shock model in addition to the 
endotoxin model would provide further support for a link between 
increased adrenergic activity and elevated arachidonic acid 
concentrations. 
Previous reports have indicated that an elevation of 
arachidonic acid metabolite levels occurs during sepsis and have 
suggested their role in subsequent pathophysiology (Cook et a1., 
1984). Our results are consistent with the hypothesis that 
plasma levels of the two arachidonic metabolites, iTxB2 and i6-
keto-PGF1a ' may be used to determine the therapeutic efficacy of 
POB. In particular, INDO rather than POB appears to be the agent 
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of choice in this sepsis model because of the associated high 
PGI2/Tx ratio. The preliminary results suggest that POB may 
attenuate the elevation of plasma TxB2 and 6-keto-FGFla in fecal 
peritonitis shock despite inability to significantly prolong 
survival time, providing additional support for a relation 
between heightened sympathetic activity and elevated eicosanoid 
levels in septic and endotoxin shock. 
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CHAPTER FIVE 
GENERAL CONCLUSIONS AND DIRECTIONS FOR FUTURE RESEARCH 
Previous reports have indicated the potential role of 
increased alpha adrenergic activity in stimulating arachidonic 
acid metabolism during endotoxemia and septicemia_ The results 
of the preceeding experiments are consistent with the above 
hypothesis, demonstrating decreased mortality during endotoxemia 
as a result of POB pretreatment. This improvement in survival 
afforded by POB is associated with attenuated levels of iTxB2 and 
i6-keto-PGFla- These results also imply that the treatment with 
the combination of POB and INDO may be more effective than either 
one of these therapeutic agents individually. In contrast, 
pretreatment with POB appeared to have no protective effect in 
preliminary experiments utilizing the fecal peritonitis model of 
septicemia, thus suggesting that the different pattern in the 
elevations of iTxB2 and i6-keto-PGFla in this shock model 
compared to the bolus endotoxin model may dictate the therapeutic 
efficacy of POB. In this model, INDO appeared to be the agent of 
choice in improving survival. Additional work utilizing this 
model is warranted, especially in examining the possible 
attenuation of iTxB2 and i6-keto-PGFla levels by POB 
pretreatment. Although POB may not enhance survival in this 
shock model, further experiments m~y be benefici~l in delineating 
the mechanism of POB-induced attenuation of these arachidonic 
acid metaboli tes •. 
Studies examining the effect of POB on iTxB2 and i6-
keto-PGFla levels in the endotoxin model could be extended to 
include additional time points. In addition to giving a more 
complete picture of arachidonic acid metbolite levels throughout 
the course of endotoxemia in both controls and POB treated 
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animals, this approach may substantiate or rule out the 
posibility that POB may only serve to delay rather than suppress 
the rise in iTxB2 and i6-keto-PGFla • 
These experiments used one alpha receptor blocker, POB, a 
nonspecific alpha-one and alpha-two receptor antagonist. This 
raises the question of whether or not the attenuation of iTxB2 
and i6-keto-PGF 1a levels in POB-treated animals was a result of 
a direct effect of the drug on reducing catecholamine-induced 
synthesis of these arachidonic acid metabolites mediated by alpha 
receptors. It is possible that blunting of sympathetic nervous 
system action on vascular beds or other target organs may have 
resulted in a improved cardiovascular status which subsequently 
resulted in a secondary reduction in eicosanoid synthesis. POB 
may also have depressed the levels of iTxB2 and i6-keto-PGF la 
through non-specific activity independent of alpha receptor 
antagonism. The use of more specific alpha blockers such as 
prazosin (Minipress) in similar experiments may shed more light 
on these potential mechanisms of action. 
These experiments were carried out under the assumption that 
endotoxemia/septicemia induced in rats is associated with 
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increased sympathetic activity which is manifested by elevated 
levels of plasma catecholamines. Jones and Romano (1984) have 
demonstrated increased catecholamine levels and increased 
catecholamine turnover in a rat bolus endotoxin similar to the 
one used for the preceeding experiment; otherwise there are no 
other reports of catehcholamine levels during shock resulting 
from endotoxemia and septicemia in rats. The finding of similar 
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elevations in catecholamines in the two shock models used for 
the preceeding experiments would provide the basis for the above 
assumption and further support a role for increased adrenergic 
activity in the elevation of arachidonic acid metabolites during 
endotoxic and septic shock. 
Further work is indicated in identifying tissue populations 
which, under in vitro conditions, could be stimulated by both 
endotoxin and exogenous catecholamines to elaborate increased 
amounts of iTxB2 and i6-keto-PGF1a. Previous work in our lab 
(Tempel et al., 1984 abstract) has suggested that POB suppresses 
endotoxin-stimulation of these arachidonic acid metabolites in 
rat peritoneal macrophages. However, this population of cells 
failed to demonstrate increased synthesis of iTxB2 and i6-keto-
PGFla in response to exogenous nonepinephrine. Similar studies 
identifying cell populations responsive to both endotoxin and 
exogenous catecholamines by increased synthesis of these 
metabolites and to POB by reduced levels of iTxB2 and i6-keto-
PGFla would indicate potential sites of action for POB, both in 
terms of the physical location of the receptors and their 
functional location in relation to the arachidonic acid cascade. 
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